greeksoup/ stock research
Stock research / United States / RCEL / Filings

Avita Medical, Inc. SEC filings

Avita Medical filed 18 documents with the SEC in the last twelve months, the latest report being the 10-Q of 6 August 2026. The latest filing, on 25 August 2026, was an S-8: s-8.

Filings in twelve months1811 of them 8-K news
Latest report10-Qfiled 6 Aug 2026
Latest filingS-825 Aug 2026
Last results, two-day move+73.8%results filed 6 Aug 2026
New to this? How to read this page
  1. Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
  2. An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
  3. The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
  4. Every filing links to the original on EDGAR, the SEC's own site.

Twelve months of filings

by kind

Most of the filings were other company news (6). Results came out 5 times.

Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.

The share price around each results release

close before to close after

Over the last 5 releases the share price moved 20.0% on average in the two days around results, the most on 6 Aug 2026 (+73.8%).

13 Jan 2026+2.9%$3.42 to $3.52
12 Feb 2026+8.3%$3.84 to $4.16
14 May 2026+7.0%$4.26 to $4.56
6 Aug 2026+73.8%$4.47 to $7.77
Daily closeResults filed

Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.

What the company told investors on 8-K

11 filings

Avita Medical's 11 news filings (8-K) were mostly about results of operations (5) and material agreement (4).

  • Results of operationsThe quarterly results release
    5 · latest 6 Aug 2026
  • Material agreementA large contract or deal was signed
    4 · latest 11 Aug 2026
  • Officer or director changeSomeone joined, left or changed role at the top
    3 · latest 4 Jun 2026
  • Shareholder voteResults of a vote at a shareholder meeting
    2 · latest 6 Aug 2026
  • Regulation FD disclosureMaterial shared with investors, often slides or a presentation
    1 · latest 1 May 2026
  • Termination of a material agreementA large contract ended
    1 · latest 13 Jan 2026
  • New financial obligationNew debt or a borrowing
    1 · latest 13 Jan 2026
  • Unregistered sale of equityShares sold privately
    1 · latest 13 Jan 2026

Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.

How it compares

every company on the site

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every filing as a table

    In the last twelve months Avita Medical, Inc. filed 18 documents with the SEC of the kinds listed here: 11 current reports (8-K), about 5 results of operations; 4 material agreement; 3 officer or director change; 2 shareholder vote; 1 regulation FD disclosure; 3 quarterly reports (10-Q), 1 employee share plan registration (S-8), 1 proxy statement (DEF 14A), 1 preliminary proxy (PRE 14A), 1 annual report (10-K). The latest, filed 25 August 2026: S-8, employee share plan registration. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

    FiledFormWhat it was aboutPeriod or event dateFiling
    25 August 2026S-8employee share plan registrationEDGAR
    11 August 20268-KMaterial agreement5 August 2026EDGAR
    6 August 20268-K/AShareholder vote3 June 2026EDGAR
    6 August 202610-Qquarterly report30 June 2026EDGAR
    6 August 20268-KResults of operations6 August 2026EDGAR
    8 June 20268-KMaterial agreement5 June 2026EDGAR
    4 June 20268-KOfficer or director change, Shareholder vote3 June 2026EDGAR
    14 May 202610-Qquarterly report31 March 2026EDGAR
    14 May 20268-KResults of operations14 May 2026EDGAR
    1 May 20268-KOfficer or director change, Regulation FD disclosure30 April 2026EDGAR
    22 April 2026DEF 14Aproxy statement22 April 2026EDGAR
    8 April 2026PRE 14Apreliminary proxy8 April 2026EDGAR
    12 February 202610-Kannual report31 December 2025EDGAR
    12 February 20268-KResults of operations12 February 2026EDGAR
    13 January 20268-KMaterial agreement, Termination of a material agreement, Results of operations, New financial obligation, Unregistered sale of equity13 January 2026EDGAR
    5 January 20268-KOfficer or director change1 January 2026EDGAR
    6 November 202510-Qquarterly report30 September 2025EDGAR
    6 November 20258-KMaterial agreement, Results of operations5 November 2025EDGAR
    An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
    Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.